Abstract
Rationality: It is a worldwide consensus that patients with mechanical valve prostheses, especially in the presence of atrial fibrillation (AF), have high risks of thromboembolic events. Antithrombotic prevention is recommended, especially with vitamin K antagonists (AVK). Warfarin is the only FDA approved VKA being used in North America and the United Kingdom. While phenprocoumon is main…